T1	Disorder 171 174	IPF
T4	GGPs 491 495	TLR4
T5	Disorder 1075 1078	IPF
T7	Disorder 523 539	hepatic fibrosis
T9	Subject 120 128	patients
T10	Anatomical_entity 619 634	tissue sections
T11	Disorder 949 952	IPF
T12	Positive_regulation 1741 1752	stimulation
T14	Subject 67 74	control
T15	Organic_compound_other 785 788	LPS
T18	Organic_compound_other 407 410	LPS
T21	GGPs 422 442	Toll-like receptor 4
T24	Cell 1559 1570	fibroblasts
T25	Anatomical_entity 346 351	lungs
T29	GGPs 860 869	receptors
T30	Disorder 193 205	lung disease
T31	Anatomical_entity 1059 1063	lung
T33	GGPs 589 593	TLR4
T34	Disorder 654 657	IPF
T35	Organic_compound_other 387 405	lipopolysaccharide
T38	Pathway 478 486	pathways
T39	GGPs 871 892	profibrotic mediators
T40	GGPs 898 907	cytokines
T42	Disorder 544 555	scleroderma
T45	Subject 1319 1326	control
T46	Disorder 140 169	Idiopathic pulmonary fibrosis
T47	Negative_regulation 1508 1522	downregulation
T48	Cell 1327 1338	fibroblasts
T50	GGPs 444 448	TLR4
T52	Cell 930 940	fibroblast
T54	GGPs 0 20	Toll-like receptor 4
T56	GGPs 1736 1740	TLR4
T57	Disorder 260 265;279 293	viral lung infection
T58	Anatomical_entity 953 958	lungs
T61	GGPs 1157 1188	connective tissue growth factor
T63	Disorder 744 747	IPF
T65	Cell 601 612	fibroblasts
T66	GGPs 1108 1113	TGF-β
T67	Disorder 238 241	IPF
T68	Subject 1551 1558	control
T71	Cell 103 114	fibroblasts
T74	Subject 702 714	normal human
T75	Disorder 324 333	pneumonia
T76	Organic_compound_other 1100 1103	LPS
T78	Gene_expression 681 691	expression
T79	Disorder 761 764	IPF
T81	Disorder 1661 1664	IPF
T82	GGPs 676 680	TLR4
T83	Cell 80 91	fibroblasts
T84	Disorder 134 137	IPF
T85	Cell 720 731	fibroblasts
T86	Disorder 1016 1039	gram-negative pneumonia
T87	Disorder 303 322	pulmonary infection
T89	GGPs 909 913	TLR4
T90	Negation_cue 96 99	not
T92	GGPs 823 828	TGF-β
T93	Cell 1665 1676	fibroblasts
T94	Disorder 597 600	IPF
T96	Cell 748 759	fibroblasts
T97	Disorder 991 994	IPF
T98	Disorder 1247 1250	IPF
T99	Subject 640 648	patients
T101	Anatomical_entity 75 79	lung
T102	Anatomical_entity 715 719	lung
T103	GGPs 1222 1227	TGF-β
T104	Organic_compound_other 1724 1727	LPS
E3	Positive_regulation:T12 Theme:T56
E5	Pathway:T38 Participant:T21
E7	Negative_regulation:T47 Theme:T77 atLoc:T24
E8	Gene_expression:T78 Theme:T82 atLoc:T10
N2	Reference T1 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N17	Reference T4 UMLS:C1321919	TLR4 protein, human
N23	Reference T5 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N32	Reference T7 UMLS:C0239946	Fibrosis, Liver
N38	Reference T9 UMLS:C0030705	Patients
N42	Reference T11 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N93	Reference T21 UMLS:C1321919	TLR4 protein, human
N107	Reference T24 UMLS:C0016030	Fibroblasts
N109	Reference T25 UMLS:C0024109	Lung
N123	Reference T29 UMLS:C0597357	receptor
N124	Reference T30 UMLS:C0024115	Lung diseases
N129	Reference T31 UMLS:C0024109	Lung
N136	Reference T33 UMLS:C1321919	TLR4 protein, human
N143	Reference T34 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N146	Reference T35 UMLS:C0023810	Lipopolysaccharides
N156	Reference T39 UMLS:C0127400	Mediator brand of benfluorex hydrochloride
N161	Reference T40 UMLS:C0079189	cytokine
N169	Reference T42 UMLS:C0011644	Scleroderma
N193	Reference T46 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N199	Reference T48 UMLS:C0016030	Fibroblasts
N202	Reference T50 UMLS:C1321919	TLR4 protein, human
N213	Reference T52 UMLS:C0016030	Fibroblasts
N222	Reference T54 UMLS:C1321919	TLR4 protein, human
N230	Reference T56 UMLS:C1321919	TLR4 protein, human
N239	Reference T58 UMLS:C0024109	Lung
N247	Reference T61 UMLS:C0110610	connective tissue growth factor
N253	Reference T63 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N260	Reference T65 UMLS:C0016030	Fibroblasts
N266	Reference T67 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N286	Reference T71 UMLS:C0016030	Fibroblasts
N295	Reference T75 UMLS:C0032285	Pneumonia
N310	Reference T79 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N320	Reference T81 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N322	Reference T82 UMLS:C1321919	TLR4 protein, human
N329	Reference T83 UMLS:C0016030	Fibroblasts
N331	Reference T84 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N335	Reference T85 UMLS:C0016030	Fibroblasts
N336	Reference T86 UMLS:C0854248	Pneumonia due to Gram negative bacteria
N338	Reference T87 UMLS:C0876973	Infectious disease of lung
N342	Reference T89 UMLS:C1321919	TLR4 protein, human
N348	Reference T90 UMLS:C1518422	Negation
N357	Reference T93 UMLS:C0016030	Fibroblasts
N358	Reference T94 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N366	Reference T96 UMLS:C0016030	Fibroblasts
N368	Reference T97 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N370	Reference T98 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N373	Reference T99 UMLS:C0030705	Patients
N382	Reference T101 UMLS:C0024109	Lung
N386	Reference T102 UMLS:C0024109	Lung
T105	Negative_regulation 32 42	attenuates
E10	Negative_regulation:T105 Cause:T54 Theme:E11
R2	Subject_Disorder Arg1:T9 Arg2:T84	
E11	Biological_process:T107 atLoc:T83
R4	member_of Arg1:T46 Arg2:T30	
R5	member_of Arg1:T75 Arg2:T87	
E13	Biological_process:T60 Cause:T119 Theme:T67
T26	Positive_regulation 412 421	activates
E14	Positive_regulation:T26 Cause:T35 Theme:T21
T59	Positive_regulation 451 461	initiating
E16	Positive_regulation:T59 Cause:T35 Theme:E32
E18	Correlation:T72 Cause:T4 Theme:T42 Theme2:T7
T88	Correlation 581 585	role
E20	Correlation:T88 atLoc:T65 Theme:T33 Theme2:T94
T8	Cell 995 997	FB
T64	Cell 765 767	FB
T108	Gene_expression 917 926	expressed
E21	Gene_expression:T108 Theme:T89 atLoc:T52
T20	GGPs 793 821	transforming growth factor-β
T27	Cell 736 738	FB
T32	Cell 1068 1070	FB
T69	Positive_regulation 1728 1735	induced
E2	Positive_regulation:T69 Cause:T104 Theme:E3
T109	Subject 1650 1656	Normal
T110	Biological_process 1698 1718	profibrotic response
E22	Biological_process:T110 Theme:T114
T77	GGPs 1526 1547	TGF-β receptor type 1
T2	Gene_expression 1369 1375	levels
E1	Gene_expression:T2 Theme:T28
T28	GGPs 1392 1408	prostaglandin E2
T3	Positive_regulation 1414 1422	elevated
E24	Positive_regulation:T3 Theme:E1
T23	Negative_regulation 1598 1605	reduced
E25	Negative_regulation:T23 Theme:E27 Cause:E7
T41	Biological_process 1606 1626	profibrotic response
E27	Biological_process:T41 
T16	Cell 1251 1253	FB
T53	Positive_regulation 1275 1284	increased
E29	Positive_regulation:T53 Theme:T6 atLoc:T16
T95	Cell 1126 1128	FB
T112	Gene_expression 1129 1137	produced
E30	Gene_expression:T112 atLoc:T95 Theme:T61
T19	Cell 1079 1081	FB
T116	Cell 984 986	FB
A5	Organism_sbjct T14 Human
A6	Patient_sbjct T14 Control
N4	Reference T14 UMLS:C0009932	Control Groups
R9	part_of Arg1:T83 Arg2:T101	
R10	part_of Arg1:T101 Arg2:T14	
N5	Reference E10 UMLS:C3463820	Inhibition
R11	part_of Arg1:T71 Arg2:T9	
A7	Organism_sbjct T9 Human
A8	Patient_sbjct T9 Patient
E31	Negative_regulation:T105 Cause:T54 Theme:E33 Cue:T90
N7	Reference E31 UMLS:C3463820	Inhibition
E33	Biological_process:T107 atLoc:T71
A9	Negated E31
T117	Positive_regulation 359 366	induces
E34	Positive_regulation:T117 Cue:T118 Cause:T87 atLoc:T25 Theme:E12
T118	Negation_cue 352 358	rarely
A10	Negated E34
N1	Reference T57 UMLS:C0729531	Viral respiratory infection
T119	Disorder 269 293	bacterial lung infection
N10	Reference T119 UMLS:C0729518	Bacterial respiratory infection
E35	Biological_process:T60 Cause:T57 Theme:T67
N13	Reference E34 UMLS:C1879547	Activation
N14	Reference T18 UMLS:C0023810	Lipopolysaccharides
N15	Reference E14 UMLS:C1879547	Activation
N18	Reference E16 UMLS:C1879547	Activation
N22	Reference E29 UMLS:C1879547	Activation
N25	Reference T10 UMLS:C2316368	Tissue section
T13	Anatomical_entity 614 618	Lung
N26	Reference T13 UMLS:C0024109	Lung
R12	part_of Arg1:T10 Arg2:T13	
R13	part_of Arg1:T13 Arg2:T99	
R14	Subject_Disorder Arg1:T99 Arg2:T34	
A13	Organism_sbjct T99 Human
A14	Patient_sbjct T99 Patient
N27	Reference E8 UMLS:C0017262	Gene Expression
A15	Speculated E8
R15	part_of Arg1:T85 Arg2:T102	
R16	part_of Arg1:T102 Arg2:T74	
A3	Organism_sbjct T68 Human
A4	Patient_sbjct T68 Control
T51	Subject 744 747	IPF
A17	Organism_sbjct T51 Human
A18	Patient_sbjct T51 Patient
R8	Subject_Disorder Arg1:T51 Arg2:T63	
N31	Reference T64 UMLS:C0016030	Fibroblasts
R17	part_of Arg1:T96 Arg2:T51	
T62	Subject 761 764	IPF
R18	Subject_Disorder Arg1:T62 Arg2:T79	
R19	part_of Arg1:T64 Arg2:T62	
A19	Organism_sbjct T62 Human
A20	Patient_sbjct T62 Patient
T70	Method_cue 837 856	expression analysis
T44	Artificial_process 774 781	exposed
E6	Artificial_process:T44 Instrument:T15 Theme:T27 Instrument2:T20 Cue:T70
E9	Artificial_process:T44 Theme:T64 Instrument:T15 Instrument2:T20
N33	Reference T20 UMLS:C0040690	Transforming Growth Factor beta
N34	Reference T92 UMLS:C0040690	Transforming Growth Factor beta
N35	Reference T104 UMLS:C0023810	Lipopolysaccharides
N36	Reference T76 UMLS:C0023810	Lipopolysaccharides
N37	Reference T15 UMLS:C0023810	Lipopolysaccharides
N39	Reference E21 UMLS:C0017262	Gene Expression
N40	Reference E30 UMLS:C0017262	Gene Expression
N41	Reference E1 UMLS:C0017262	Gene Expression
T36	Subject 949 952	IPF
R21	Subject_Disorder Arg1:T36 Arg2:T11	
A21	Organism_sbjct T36 Human
A22	Patient_sbjct T36 Patient
R22	part_of Arg1:T58 Arg2:T36	
R23	part_of Arg1:T52 Arg2:T58	
N44	Reference T8 UMLS:C0016030	Fibroblasts
E15	Gene_expression:T108 atLoc:T8 Theme:T89
E17	Gene_expression:T108 atLoc:T116 Theme:T89
N45	Reference E17 UMLS:C0017262	Gene Expression
N47	Reference E15 UMLS:C0017262	Gene Expression
T73	Subject 991 994	IPF
R24	Subject_Disorder Arg1:T73 Arg2:T97	
R25	part_of Arg1:T8 Arg2:T73	
T91	Artificial_process 1087 1096	coexposed
E36	Artificial_process:T91 Instrument:T76 Instrument2:T66 Theme:T32
N24	Reference T19 UMLS:C0016030	Fibroblasts
A23	Organism_sbjct T73 Human
A24	Patient_sbjct T73 Patient
N43	Reference E6 UMLS:C0332157	Exposure to
N48	Reference E9 UMLS:C0332157	Exposure to
N49	Reference E36 UMLS:C0332157	Exposure to
E37	Artificial_process:T91 Theme:T19 Instrument:T76 Instrument2:T66
N50	Reference E37 UMLS:C0332157	Exposure to
N51	Reference T103 UMLS:C0040690	Transforming Growth Factor beta
T100	Positive_regulation 1194 1207	costimulation
E38	Positive_regulation:T100 Cause:T66 Theme:E30
N52	Reference T66 UMLS:C0040690	Transforming Growth Factor beta
N53	Reference E38 UMLS:C1879547	Activation
R26	part_of Arg1:T48 Arg2:T45	
T17	Subject 1247 1250	IPF
A25	Organism_sbjct T17 Human
A26	Patient_sbjct T17 Patient
R27	part_of Arg1:T16 Arg2:T17	
R28	Subject_Disorder Arg1:T17 Arg2:T98	
N54	Reference T28 UMLS:C3813211	Prostaglandin E2
N55	Reference E24 UMLS:C1879547	Activation
R29	part_of Arg1:T24 Arg2:T68	
N56	Reference E25 UMLS:C3463820	Inhibition
T37	Subject 1661 1664	IPF
A29	Organism_sbjct T37 Human
A30	Patient_sbjct T37 Patient
T114	Cell 1665 1676	fibroblasts
R30	Subject_Disorder Arg1:T37 Arg2:T81	
R31	part_of Arg1:T114 Arg2:T37	
R32	part_of Arg1:T93 Arg2:T109	
N61	Reference T77 UMLS:C1704256	Transforming Growth Factor Beta 1
N62	Reference T114 UMLS:C0016030	Fibroblasts
N29	Reference T68 UMLS:C0009932	Control Groups
N30	Reference T45 UMLS:C0009932	Control Groups
N60	Reference T109 UMLS:C0009932	Control Groups
A31	Organism_sbjct T109 Human
A32	Patient_sbjct T109 Control
A33	Organism_sbjct T45 Human
A34	Patient_sbjct T45 Control
A35	Organism_sbjct T74 Human
A36	Patient_sbjct T74 Control
N28	Reference T74 UMLS:C0009932	Control Groups
N64	Reference E2 UMLS:C1879547	Activation
N46	Reference E3 UMLS:C1879547	Activation
N6	Reference E33 UMLS:C0596570	fibrogenesis
N3	Reference E11 UMLS:C0596570	fibrogenesis
T106	Biological_process 367 375	fibrosis
E12	Biological_process:T106 
N8	Reference E12 UMLS:C0596570	fibrogenesis
N9	Reference E27 UMLS:C0596570	fibrogenesis
N57	Reference E22 UMLS:C0596570	fibrogenesis
T49	Biological_process 1379 1391	antifibrotic
E23	Biological_process:T49 Participant:T28
T107	Biological_process 43 63	profibrotic response
T115	Subject 1075 1078	IPF
R33	Subject_Disorder Arg1:T115 Arg2:T5	
T120	Subject 1123 1125	NL
N65	Reference T120 UMLS:C0009932	Control Groups
A37	Organism_sbjct T120 Human
A38	Patient_sbjct T120 Control
T6	GGPs 1285 1304	profibrotic markers
N63	Reference T6 UMLS:C0005516	Biological Markers
T111	Positive_regulation 1345 1358	costimulation
E28	Positive_regulation:T111 Theme:E29 Cause:T66
E26	Positive_regulation:T111 Theme:E29 Cause:T76
N58	Reference E26 UMLS:C1879547	Activation
N59	Reference E28 UMLS:C1879547	Activation
T121	Anatomical_entity 193 197	lung
N66	Reference T121 UMLS:C0024109	Lung
T122	Anatomical_entity 279 283	lung
N67	Reference T122 UMLS:C0024109	Lung
N69	Reference T32 UMLS:C0016030	Fibroblasts
T123	Subject 733 735	NL
A12	Organism_sbjct T123 Human
A16	Patient_sbjct T123 Control
T124	Subject 1065 1067	NL
A39	Organism_sbjct T124 Human
A40	Patient_sbjct T124 Control
T43	Localization 941 945	foci
E4	Localization:T43 Theme:T52
N21	Reference E4 UMLS:C0475264	localization
N70	Reference T118 UMLS:C1518422	Negation
T55	Subject 338 345	healthy
A1	Organism_sbjct T55 Human
A2	Patient_sbjct T55 Control
N71	Reference T55 UMLS:C2986479	Healthy Control
R1	part_of Arg1:T25 Arg2:T55	
R3	Subject_Disorder Arg1:T55 Arg2:T87	
T60	Biological_process 242 254	deteriorates
N12	Reference E13 UMLS:C4086268	Exacerbation
N11	Reference E35 UMLS:C4086268	Exacerbation
T22	Biological_process 462 477	proinflammatory
E32	Biological_process:T22 Theme:E5
N72	Reference E32 UMLS:C1155266	inflammatory response
N16	Reference E5 UMLS:C0037080	Signal Pathways
T72	Correlation 513 519	linked
N20	Reference E18 UMLS:C0332281	Associated with
N19	Reference E20 UMLS:C0332281	Associated with
N68	Reference T123 UMLS:C0009932	Control Groups
N73	Reference T51 UMLS:C0030705	Patients
N74	Reference T62 UMLS:C0030705	Patients
T80	Subject 981 983	NL
N75	Reference T80 UMLS:C0009932	Control Groups
A11	Organism_sbjct T80 Human
A27	Patient_sbjct T80 Control
R6	part_of Arg1:T116 Arg2:T80	
R7	part_of Arg1:T32 Arg2:T124	
E19	Biological_process:T110 Theme:T93
N76	Reference E19 UMLS:C0596570	fibrogenesis
N77	Reference E7 UMLS:C3463820	Inhibition
